JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(1):11-16

Extrusion/spheronization: an important method for the production of the pellet dosage form

A. Häring, M. Rabišková
Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav technologie léků

Extrusion/spheronization is the method used to manufacture pellets with a high content of the active ingredient. It produces particles of very good physical properties (strength, friability, porosity, density, uniform diameter), which are well processed in further steps, i.e., when they are coated, compressed or filled into hard gelatine capsules. The process of extrusion/spheroniztion consists of several consequential steps, which are influenced by numerous formulation and process factors. Though there are general rules for optimization of the process, due to its complexity the same rules need not necessarily be valid for similar systems and very often it is necessary to find again the optimal production condition for a new formulation and equipment. The paper informs about the technology, equipment, and the result achieved in the field.

Keywords: pellets; extrusion, spheronization; extrudate; formulation factors; process factors

Received: November 21, 2006; Accepted: November 30, 2006; Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Häring A, Rabišková M. Extrusion/spheronization: an important method for the production of the pellet dosage form. Čes. slov. farm. 2007;56(1):11-16.
Download citation

References

  1. Kolektiv autorů: Český lékopis 2005, 1. díl. Praha, Grada Publishing, 2005, 877 s.
  2. Zathurecký, L., Chalabala, M.: Biofarmácia a farmakokinetika. Osveta, Martin, 1989, s. 431.
  3. Gurny, R., Junginger, H., Peppas, N. A.: Pulsatile Drug Delivery, Stuttgart, Wissenschaftliche Verlaggesellschaft, 1993, 186 s.
  4. Janovská, L., Vetchý, D., Rabišková, M.: Čes. slov. Farm., 2006; 55, 203-209.
  5. Rowe, R. C.: Pharmacy International, 1985; 5, 119-123. Go to original source...
  6. Rabišková, M.: Čes. slov. Farm., 1998; 47, 199-205. Go to original source...
  7. Nakahara, N.: US Patent 3, 277, 520, 1964.
  8. Reynolds, A. D.: Manufacture Chemistry and Aerosol News, 1970; 41, 40-43.
  9. Conine, J. W., Hadley, H. R.: Drug and Cosmetic Industry, 1970; 90, 38-41.
  10. Peréz, J. P., Rabišková, M.: Čes. slov. Farm., 2002; 51, 244-247.
  11. Fekete, R., Zelkó, R., Marton, S. et al.: Drug Dev. Ind. Pharm., 1998; 24, 1073-1076. Go to original source... Go to PubMed...
  12. Kristensen, H. G., Schĺfer, T.: Drug Dev. Ind. Pharm., 1987; 13, 803-872. Go to original source...
  13. Chien, T., Nuessle, N.: Pharm. Technol., 1995; 9, 42-48.
  14. Vervaet, C., Baert, L., Remon, J. P.: Int. J. Pharm., 1995; 116, 131-146. Go to original source...
  15. Mesiha, M. S., Vallés, J. A: Drug Dev. Ind. Pharm., 1993; 19, 943-959. Go to original source...
  16. Pinto, J. F., Buckton, G., Newton, J. M.: Int. J. Pharm., 1993; 83, 187-196. Go to original source...
  17. Kristensen, H. G.: Powder Technol., 1996; 88, 197-202. Go to original source...
  18. Ku, C., Joshi, Y., Bergum, J., Jain, N.: Drug Dev. Ind. Pharm., 1993; 19, 1505-1519. Go to original source...
  19. Woodruff, C., Nuessle, N.: J. Pharm. Sci., 1972; 61, 787790. Go to original source... Go to PubMed...
  20. Hellén, L., Ritala, M., Yliruusi, J. et al.: Pharmaceutical Technology and International Biophysics, 1992; 4, 5060.
  21. Hellén, L., Yliruusi, J.: Int. J. Pharm., 1993; 96, 217223. Go to original source...
  22. Hellén, L., Yliruusi, J., Kristoffersson, E.: Int. J. Pharm., 1993; 96, 205-216. Go to original source...
  23. Baert, L., Fanara, D., De Baets, P. et al.: J. Pharm. Pharmacol., 1991; 43, 745-749. Go to original source... Go to PubMed...
  24. Newton, J. M.: S.T.P. Pharma, 1990; 6, 396-398.
  25. Fielden, K., Newton, J., Rowe, R.: J. Pharm. Pharmacol., 1989; 41, 217-221. Go to original source... Go to PubMed...
  26. Fielden, K., Newton, J., Rowe, R.: Int. J. Pharm., 1992; 81, 205-224. Go to original source...
  27. Fielden, K., Newton, J., Rowe, R.: Int. J. Pharm., 1993; 97, 79-92. Go to original source...
  28. Torres-Suárez, A., Gil-Alegre, M.: In: Encyclopedia of Pharmaceutical Technology (Swarbrick, J., Boylan, J., ed.), Volume 16. New York, Marcel Dekker, 1997, 363-402.
  29. Newton, J. M.: In: Encyclopedia of Pharmaceutical Technology (Swarbrick, J., Boylan, J., ed.), Volume 14. New York, Marcel Dekker, 1996,181-205.
  30. Hall, H., Pondell, R.: In: Controlled Release Technologies: Methods, Theory, and Applications, (Kydonieus, A. F. ed.), Volume 2. Boca Raton, CRC Press, 1980, 137 s.
  31. Schĺfer, T., Taagegaard, B., Thomsen, L. et al.: Eur. J. Pharm. Sci., 1993; 1, 133-141. Go to original source...
  32. Jerwanska, E., Alderborn, G., Newton, J. M. et al.: Int. J. Pharm., 1995; 121, 65-71. Go to original source...
  33. Rabišková, M.: In: Vilstrup, P.: Microencapsulation of Food Ingredients. England, Leather Food RA, 2001, 224248.
  34. Hasznos, L., Langer, I., Gyarmathy, M.: Drug. Dev. Ind. Pharm., 1992; 18, 409-437. Go to original source...
  35. Fielden, K., Newton, J. M.: In: Encyclopedia of Pharmaceutical Technology. (Swarbrick, J., Boylan, J. C. eds.). Volume 5. New York and Basel, Marcel Dekker Inc., 1996, 395-442.
  36. Peh, K., Yuen, K.: Drug. Dev. Ind. Pharm., 1995; 21, 1545-1555. Go to original source...
  37. Hicks, D., Freese, H.: In: Pharmaceutical Pelletization Technology. (Ghebre-Sellassie, I., ed.), New York and Basel, Marcel Dekker Inc., 1989, 71-100.
  38. Peréz, J. P.: Peletová léková forma s časově programovaným uvolňováním antiastmatika. Projekt dizertační práce, Ústav technologie léků, FaF VFU Brno, 2001.
  39. O'Connor R., Schwartz J.: Pharm. Res.,1993; 10, 356361. Go to original source... Go to PubMed...
  40. Baert, L., Remon, J., Knight, P. et al.: Int. J. Pharm., 1992; 86, 187-192. Go to original source...
  41. Kleinebudde P., Lindner H.: Int. J. Pharm., 1993; 94, 49-58. Go to original source...
  42. O'Connor, R., Schwartz, J.: In: Pharmaceutical Pelletization Technology (Ghebre-Sellassie, I., ed.), New York and Basel, Marcel Dekker, 1989, 187-216.
  43. Newton, J., Chapman, S., Rowe, R.: Int. J. Pharm., 1995; 120, 101-109. Go to original source...
  44. Kristensen, H. G., Schĺfer, T., Kleinebudde, P.: Pharm. Dev. Technol., 2000; 5, 247-256. Go to original source... Go to PubMed...
  45. Kleinebudde, P.: Int. J. Pharm., 1994; 109, 209-219. Go to original source...
  46. Pérez, J. P., Rabišková, M.: Int. J. Pharm. 2002; 242, 349-351. Go to original source... Go to PubMed...
  47. Umprayn, K, Chitropas, P., Amarekajorn, S.: Drug Dev. Ind. Pharm., 1999; 25, 45-61. Go to original source... Go to PubMed...
  48. Tomer, G., Podczeck, F., Newton, J. M.: Int. J. Pharm., 2001; 217, 237-248. Go to original source... Go to PubMed...
  49. Noché, C., Huet de Barochez, B., Brossard, C. et al.: Pharm. Tech. Europe, 1994; 4, 39-46.
  50. Millili, G., Schwartz, J.: Drug Dev. Ind. Pharm., 1990; 16, 1411-1426. Go to original source...
  51. Elbers, J.A.C., Bakkenes, H. W., Fokkens, J. G.: Drug Dev. Ind. Pharm., 1992; 18, 501-517. Go to original source...
  52. Baert, L., Remon, J. P.: Int. J. Pharm., 1993; 95, 135141. Go to original source...
  53. Blanqué, D., Sternagel, H., Podczeck, F.: Int. J. Pharm., 1995; 119, 203-211. Go to original source...
  54. Goodhart, F., Ronald, J., Ninger, F.: J. Pharm. Sci., 1973; 62, 133-136. Go to original source... Go to PubMed...
  55. Shah, R., Kabadi, M., Pope, D.: Pharm. Res., 1994; 11, 355-360. Go to original source... Go to PubMed...
  56. Gouldson, M., Deasy, P.: J. Microencapsulation, 1997; 14, 137-153. Go to original source... Go to PubMed...
  57. Kleinebudde, P., Schröder, M., Schultz, P.: Pharm. Dev. Technol., 1999; 4, 102-113.
  58. Wan, L., Heng, P., Liew, C.: Int. J. Pharm., 1993; 96, 5965. Go to original source...
  59. Zhang, G., Schwartz, J., Schnaare, R.: Drug Dev. Ind. Pharm., 1990; 16, 1171-1184. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.